The AARP report suggests the spending cap could be huge for Medicare enrollees who take costly drugs for cancer, rheumatoid arthritis, and other conditions.
More Stories
Bank of America tops estimates on better-than-expected investment banking, interest income
Bank of America's results hinge on interest rates and their impact on net interest income.
Target says its holiday sales were better than expected — but its profits weren’t
The big-box retailer's report indicates that deals and promotional events motivated shoppers.
JPMorgan Chase is boosting buybacks even after CEO Jamie Dimon called the stock expensive
Fresh off a record year for profit and revenue, JPMorgan is facing questions over what CFO Jeremy Barnum admitted was...
DOT sues Southwest, fines Frontier for ‘chronically delayed flights’
The Department of Transportation has sued Southwest Airlines, alleging the carrier operated chronically delayed flights.
FTC sues Deere, alleging equipment repair ‘monopoly’ raises costs for farmers
The Federal Trade Commission has filed a lawsuit against agricultural equipment giant Deere & Company, alleging it holds a monopoly...
Bristol Myers Squibb says Alzheimer’s is the biggest market for new schizophrenia drug
Bristol Myers Squibb plans to release initial late-stage trial data on Cobenfy in Alzheimer's-related psychosis during the latter part of...